EzraBio provides kits for QEZ-seq, including rRNA depletion reagents.
EzraBio has raised $256K in total funding. The most recent round was Grant. The last funding was announced in April 2022.
EzraBio's investors include National Science Foundation.
EzraBio is headquartered in Ithaca, United States.
EzraBio provides kits for QEZ-seq, including rRNA depletion reagents.
EzraBio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"EzraBio — Funding & Investors." VCBacked, April 1, 2022, https://www.vcbacked.co/company/ezrabio. Accessed September 30, 2026.
VCBacked. (2022). EzraBio — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/ezrabio
{{cite web |title=EzraBio — Funding & Investors |url=https://www.vcbacked.co/company/ezrabio |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated